ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress

October 31, 1986

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

Kansas Gov. Sebelius Nominated For HHS

March 6, 2009

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014